Anticancer therapy targeting the ErbB family of receptor tyrosine kinases

被引：122

作者：

Slichenmyer, WJ

Fry, DW

机构：

[1] Pfizer Global Res & Dev, Dept Clin Oncol Dev, Ann Arbor, MI 48105 USA

[2] Pfizer Global Res & Dev, Dept Canc Res, Ann Arbor, MI 48105 USA

来源：

SEMINARS IN ONCOLOGY | 2001年 / 28卷 / 05期

关键词：

D O I：

10.1053/sonc.2001.28557

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：67 / 79

页数：13

共 128 条

[61] Expression of mRNA for heregulin and its receptor, ErbB-3 and ErbB-4, in human upper gastrointestinal mucosa [J].

Kataoka, H ;

Joh, T ;

Kasugai, K ;

Okayama, N ;

Moriyama, A ;

Asai, K ;

Kato, T .

LIFE SCIENCES, 1998, 63 (07) :553-564

[62]

Keler T, 1997, CANCER RES, V57, P4008

[63]

Kirschbaum MH, 2000, J CELL BIOCHEM, P52

[64]

Klohs Wayne D., 1997, Current Opinion in Oncology, V9, P562, DOI 10.1097/00001622-199711000-00012

[65] A potential autocrine loop between heregulin-alpha and erbB-3 receptor in human prostatic adenocarcinoma [J].

Leung, HY ;

Weston, J ;

Gullick, WJ ;

Williams, G .

BRITISH JOURNAL OF UROLOGY, 1997, 79 (02) :212-216

[66] Tyrosine kinase inhibitors in preclinical development [J].

Levitt, ML ;

Koty, PP .

INVESTIGATIONAL NEW DRUGS, 1999, 17 (03) :213-226

[67] INVOLVEMENT OF PP60(C-SRC) WITH 2 MAJOR SIGNALING PATHWAYS IN HUMAN BREAST-CANCER [J].

LUTTRELL, DK ;

LEE, A ;

LANSING, TJ ;

CROSBY, RM ;

JUNG, KD ;

WILLARD, D ;

LUTHER, M ;

RODRIGUEZ, M ;

BERMAN, J ;

GILMER, TM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (01) :83-87

[68]

MAYGARDEN SJ, 1994, MODERN PATHOL, V7, P930

[69]

Mendelsohn J, 2000, Trans Am Clin Climatol Assoc, V111, P95

[70]

MENDELSOHN J, 1999, P AN M AM SOC CLIN, V18, pA389

← 2 3 4 5 6 7 8 9 10 11 →